ResearcherTokyo Dental College Ichikawa General HospitalActive in the last 2 years
Yutaka Takigawa
Matched on ORCID iD 0000-0002-5353-8707; OpenAlex author ID A5056636706. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 2 papers · 2025: 1 paper
Papers 3
- Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Cancer (TOSPAC-02): A Phase 2 Clinical Tria… Co-author DOI 10.1245/s10434-025-17661-7↗
- Adjuvant 5-fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer. Co-author DOI 10.1002/cam4.7459↗
- Investigating the early diagnosis of pancreatic cancer by surveillance of patients with "K-sign" of the pancreas by computed tomography: A prospective study. Co-author DOI 10.1002/jhbp.1411↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Junichi Matsui · 3 shared papers, 2024–2025 · strength 0.68
- Paper Investigating the early diagnosis of pancreatic cancer by surveillance of patients with "K-sign" of the pancreas by com… DOI 10.1002/jhbp.1411↗
- Paper Perioperative 5-Fluorouracil and Portal Vein Infusion Chemotherapy Followed by Adjuvant S-1 for Resected Pancreatic Can… DOI 10.1245/s10434-025-17661-7↗
- Paper Adjuvant 5-fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer. DOI 10.1002/cam4.7459↗
- Koichi Aiura · 2 shared papers, 2024–2025 · strength 0.40
- Yutaka Endo · 2 shared papers, 2024–2025 · strength 0.40
- Minoru Kitago · 2 shared papers, 2024–2025 · strength 0.40
- Yuta Abe · 2 shared papers, 2024–2025 · strength 0.40
- Yutaka Nakano · 2 shared papers, 2024–2025 · strength 0.40
- Aya Sasaki · 1 shared paper, 2024 · strength 0.28
- Sojun Hoshimoto · 1 shared paper, 2025 · strength 0.22
- Yosuke Uematsu · 1 shared paper, 2025 · strength 0.22
- Yuko Kitagawa · 1 shared paper, 2025 · strength 0.22
- Yuko Kitagawa · 1 shared paper, 2024 · strength 0.18
- Minoru Tanabe · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.